Clinical trials
Infarction clinical trials
Below are recruiting infarction clinical trials, each written for real people, not researchers. We’re tracking 392 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05759078RecruitingPhase 4
IV iron treatment after a heart attack for low-iron patients
This trial tests whether giving IV ferric carboxymaltose can lower the risk of death and heart complications after a recent heart attack, and improve quality of life. It is for adults with low iron levels and specific heart/health risk factors identified soon after their heart attack.
Bydgoszcz, Kuyavian-Pomeranian VoivodeshipAges 18–90 - NCT06742125Recruiting
Drug balloon vs. stent for heart attack treatment
This trial compares two ways to treat a major heart attack: using a drug-coated balloon or a drug-eluting stent. If you are having a heart attack and need emergency angioplasty, you may qualify if your artery blockages meet specific size limits and you have no bleeding risks or allergies to the medicines used.
Hangzhou, ZhejiangAges 18 years+ - NCT06746233Recruiting
Balloon versus stent for heart attack treatment
This trial compares a drug-coated balloon to a drug-coated stent for opening blocked arteries during a heart attack. It aims to see which device works better for patients having a specific type of heart attack called STEMI.
Banja LukaAges 18 years+ - NCT06744322Recruiting
Fast discharge after a heart attack
This trial tests if it's safe to send patients home quickly after a mild heart attack. It may help those who had a successful procedure to open a blocked artery and are stable enough to leave the hospital sooner.
Wiener Neustadt, Lower AustriaAges 18 years+ - NCT06738498Recruiting
Delays and heart attack outcomes study
This study looks at how time delays before and during hospital care affect recovery after a heart attack. It may help identify ways to get faster treatment and improve survival.
BaghdadAges 18 years+ - NCT06732648RecruitingPhase 2/Phase 3
Testing a new drug for severe brain swelling after a large stroke
This trial tests a new drug called HRS8179 to reduce severe brain swelling after a large stroke. If you have a major stroke on one side of the brain and can start treatment within 10 hours, this study may help prevent dangerous pressure buildup.
Beijing, Beijing MunicipalityAges 18–80 - NCT06689566Recruiting
Genistein for heart attack recovery and inflammation
This study tests whether genistein, a natural compound found in soy, can help reduce inflammation and improve heart health in people who have had a heart attack and are overweight or have other risk factors.
Taipei, TaiwanAges 18 years+ - NCT05689385Recruiting
Online cardiac rehab after a heart attack you can do at home
This trial tests an eHealth (phone or internet-based) cardiac rehabilitation program for people after a heart attack, meant to help you recover with safer activity guidance. It may fit you if you’re not able to go to a rehab clinic in person.
TaipeiAges 20 years+ - NCT06566625Recruiting
MRI before heart catheterization for heart attack
This trial compares using a cardiac MRI before the standard catheterization (angiogram) in people with a suspected heart attack that doesn't show the typical ECG changes. It aims to see if the MRI can help guide decisions and avoid unnecessary procedures.
Stockholm, SwedenAges 18 years+ - NCT06562582RecruitingPhase 4
Starting heart drugs after a STEMI heart attack
This study tests whether starting a beta blocker and an SGLT2 inhibitor right after a heart attack can help preserve heart function. It is for STEMI patients who have not yet been treated with these medicines.
GothenburgAges 18 years+ - NCT05476991RecruitingPhase 3
Low-dose colchicine plus ticagrelor to prevent repeat stroke
This Phase 3 study tests whether low-dose colchicine added to ticagrelor (a blood-thinning medicine) helps prevent another ischemic stroke in people whose first stroke was caused by clogged arteries. It aims to lower the risk of repeat stroke after recovery from a recent event.
Paris, ParisAges 18 years+ - NCT04046237Recruiting
Treating gum disease to study heart artery inflammation after a heart attack
This study tests whether treating severe gum disease in people who recently had a heart attack can reduce inflammation in the artery plaque. It may help researchers understand if gum treatment could benefit heart health after a heart attack.
ParisAges 30–70 - NCT06343844Recruiting
Heart attack recovery differences between men and women
This study looks at how men and women recover differently after a first heart attack. By comparing heart function over time, researchers hope to find better ways to treat each gender.
AngersAges 18 years+ - NCT06336317RecruitingPhase 4
Flu vaccine after heart attack: effect on heart inflammation
This trial tests whether getting a flu vaccine shortly after a heart attack can reduce inflammation in the heart. If you've recently had a non-ST-segment elevation heart attack and a stent placed, you may be able to join.
AarhusAges 18 years+ - NCT04130269Recruiting
Study of stress, anxiety, and pain after heart attack
This study looks at how anxiety, stress, and pain may affect people after a heart attack. It may help researchers understand who could benefit from supportive strategies after myocardial infarction (heart attack).
Graz, StyriaAges 19–90 - NCT06271577Recruiting
Smartphone ECG for heart attack detection
This study tests whether a smartphone can take a 12-lead ECG (a heart tracing) quickly when someone arrives at the ER with chest pain, to help doctors spot a heart attack sooner.
Rochester, MinnesotaAges 18 years+ - NCT06252168Recruiting
A registry for heart attack patients in Tomsk
This study collects information from people in Tomsk who have had a heart attack (acute myocardial infarction). It looks at medical records to better understand heart attacks and improve treatment.
TomskAges 20 years+ - NCT06209723Recruiting
Vegetarian diet study for recent heart attack patients and their partners
This study tests whether a vegetarian diet can help the immune system recover after a heart attack. It is for people who recently had a heart attack and their healthy partners.
NijmegenAges 18 years+ - NCT05896826Recruiting
Magnetocardiography to better spot heart attack patients
This study tests whether magnetocardiography—a scan that measures heart signals using magnets—can more accurately identify myocardial infarction (heart attack). It may help doctors detect heart attacks faster and more accurately using safer, non-invasive testing.
Jinan, ShandongAges 18–79 - NCT06174753RecruitingPhase 3
Dapagliflozin for large heart attacks (STEMI)
This trial tests whether a diabetes drug called dapagliflozin can help people recover from a major heart attack (STEMI). You may qualify if you had a large heart attack within the last 12 hours and have not had a heart attack before.
Ottawa, OntarioAges 18 years+ - NCT06147986RecruitingPhase 2
Stem cell treatment after heart attack
This trial tests if umbilical cord stem cells, given alongside standard care, can help people who have had a major heart attack (STEMI). The cells are infused into the heart artery to possibly improve heart function. You may qualify if you are between 20 and 76, had a heart attack within the last 12 hours, and received a stent, and your heart's pumping ability is moderately reduced.
TaichungAges 20–75 - NCT06113510Recruiting
Clot imaging for heart attacks with clear arteries
This study uses a special type of MRI to look for tiny blood clots in the heart arteries that may have caused a heart attack even when standard tests show no major blockages. It aims to better understand the cause of heart attacks in people with this uncommon pattern.
EdinburghAges 18 years+ - NCT05920629Recruiting
Moderate drinking and heart recovery after a recent heart attack
This study looks at whether moderate alcohol intake affects heart function after a recent heart attack. You may be asked to follow a specific plan and attend scheduled visits so researchers can measure changes in your heart and overall recovery.
Basel, BaselAges 18 years+ - NCT05892042Recruiting
Anticoagulant treatment for a heart clot after a heart attack
This trial studies whether a specific blood thinner can better treat a left-side heart clot found soon after a heart attack. It may help prevent the clot from getting worse or causing complications.
Changchun, JilinAges 18–80
Hear when a new Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infarction?
- Yes. Clin2 currently lists 392 recruiting infarction studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infarction trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infarction trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.